Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 657

1.

Antimicrobial Nitric Oxide Releasing Contact Lens Gels for the Treatment of Microbial Keratitis.

Aveyard J, Deller RC, Lace R, Williams RL, Kaye SB, Kolegraff KN, Curran JM, D'Sa RA.

ACS Appl Mater Interfaces. 2019 Oct 2. doi: 10.1021/acsami.9b13958. [Epub ahead of print]

PMID:
31532610
2.

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.

Jones RL, Ratain MJ, O'Dwyer PJ, Siu LL, Jassem J, Medioni J, DeJonge M, Rudin C, Sawyer M, Khayat D, Awada A, de Vos-Geelen JMPGM, Evans TRJ, Obel J, Brockstein B, DeGreve J, Baurain JF, Maki R, D'Adamo D, Dickson M, Undevia S, Geary D, Janisch L, Bedard PL, Abdul Razak AR, Kristeleit R, Vitfell-Rasmussen J, Walters I, Kaye SB, Schwartz G.

Eur J Cancer. 2019 Oct;120:132-139. doi: 10.1016/j.ejca.2019.07.024. Epub 2019 Sep 12.

3.

Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival.

Sibley D, Hopkinson CL, Tuft SJ, Kaye SB, Larkin DFP; National Health Service Blood and Transplant Ocular Tissue Advisory Group and contributing ophthalmologists (OTAG Study 26).

Br J Ophthalmol. 2019 Aug 28. pii: bjophthalmol-2019-314200. doi: 10.1136/bjophthalmol-2019-314200. [Epub ahead of print]

PMID:
31462418
4.

Increasing Donor Endothelial Cell Pool by Culturing Cells from Discarded Pieces of Human Donor Corneas for Regenerative Treatments.

Parekh M, Romano V, Ruzza A, Kaye SB, Ponzin D, Ahmad S, Ferrari S.

J Ophthalmol. 2019 Jul 21;2019:2525384. doi: 10.1155/2019/2525384. eCollection 2019.

5.

Use of a corneal impression membrane and PCR for the detection of herpes simplex virus type-1.

Brunner M, Somerville T, Corless CE, Myneni J, Rajhbeharrysingh T, Tiew S, Neal T, Kaye SB.

J Med Microbiol. 2019 Sep;68(9):1324-1329. doi: 10.1099/jmm.0.001041. Epub 2019 Jul 24.

PMID:
31355739
6.

Metagenomics in ophthalmology: current findings and future prospectives.

Borroni D, Romano V, Kaye SB, Somerville T, Napoli L, Fasolo A, Gallon P, Ponzin D, Esposito A, Ferrari S.

BMJ Open Ophthalmol. 2019 Jun 4;4(1):e000248. doi: 10.1136/bmjophth-2018-000248. eCollection 2019. Review. Erratum in: BMJ Open Ophthalmol. 2019 Jun 27;4(1):e000248corr1.

7.

A decade of clinical development of PARP inhibitors in perspective.

Mateo J, Lord CJ, Serra V, Tutt A, Balmaña J, Castroviejo-Bermejo M, Cruz C, Oaknin A, Kaye SB, de Bono JS.

Ann Oncol. 2019 Sep 1;30(9):1437-1447. doi: 10.1093/annonc/mdz192.

8.

Next-generation sequencing for the detection of microorganisms present in human donor corneal preservation medium.

Parekh M, Borroni D, Romano V, Kaye SB, Camposampiero D, Ponzin D, Ferrari S.

BMJ Open Ophthalmol. 2019 Apr 20;4(1):e000246. doi: 10.1136/bmjophth-2018-000246. eCollection 2019.

9.

Culturing Discarded Peripheral Human Corneal Endothelial Cells From the Tissues Deemed for Preloaded DMEK Transplants.

Parekh M, Romano V, Ruzza A, Kaye SB, Ponzin D, Ahmad S, Ferrari S.

Cornea. 2019 Sep;38(9):1175-1181. doi: 10.1097/ICO.0000000000001998.

PMID:
31169610
10.

Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.

Moss CA, Cojocaru E, Hanwell J, Ward S, Xu W, van Zyl M, O'Leary L, de Bono JS, Banerji U, Kaye SB, Minchom A, George AJ, Lopez J, McVeigh TP.

Eur J Cancer. 2019 Jun;114:97-106. doi: 10.1016/j.ejca.2019.04.009. Epub 2019 May 16.

PMID:
31078974
11.

Intraobserver reproducibility and interobserver agreement of demarcation line depth measurements following corneal cross linking.

Tzamalis A, Vinciguerra R, Romano V, Arbabi E, Batterbury M, Kaye SB.

Eur J Ophthalmol. 2019 Mar 12:1120672119835116. doi: 10.1177/1120672119835116. [Epub ahead of print]

PMID:
30857417
12.

Assessment of the Association Between In Vivo Corneal Biomechanical Changes After Corneal Cross-linking and Depth of Demarcation Line.

Vinciguerra R, Tzamalis A, Romano V, Arbabi EM, Batterbury M, Kaye SB.

J Refract Surg. 2019 Mar 1;35(3):202-206. doi: 10.3928/1081597X-20190124-01.

PMID:
30855098
13.

Iontophoresis CXL With and Without Epithelial Debridement Versus Standard CXL: 2-Year Clinical Results of a Prospective Clinical Study.

Vinciguerra P, Rosetta P, Legrottaglie EF, Morenghi E, Mazzotta C, Kaye SB, Vinciguerra R.

J Refract Surg. 2019 Mar 1;35(3):184-190. doi: 10.3928/1081597X-20190128-01.

PMID:
30855096
14.

Biobanking of Dehydrated Human Donor Corneal Stroma to Increase the Supply of Anterior Lamellar Grafts.

Romano V, Levis HJ, Gallon P, Lace R, Borroni D, Ponzin D, Ruzza A, Kaye SB, Ferrari S, Parekh M.

Cornea. 2019 Apr;38(4):480-484. doi: 10.1097/ICO.0000000000001876.

PMID:
30681513
15.

A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.

Kiire CA, Stewart RMK, Srinivasan S, Heimann H, Kaye SB, Dhillon B.

Eye (Lond). 2019 Feb;33(2):283-294. doi: 10.1038/s41433-018-0217-x. Epub 2018 Dec 28.

PMID:
30593587
16.

Cross-Country Transportation Efficacy and Clinical Outcomes of Preloaded Large-Diameter Ultra-Thin Descemet Stripping Automated Endothelial Keratoplasty Grafts.

Parekh M, Ruzza A, Steger B, Willoughby CE, Rehman S, Ferrari S, Ponzin D, Kaye SB, Romano V.

Cornea. 2019 Jan;38(1):30-34. doi: 10.1097/ICO.0000000000001777.

PMID:
30418273
17.

Functional Staging of Corneal Neovascularization Using Fluorescein and Indocyanine Green Angiography.

Palme C, Romano V, Brunner M, Vinciguerra R, Kaye SB, Steger B.

Transl Vis Sci Technol. 2018 Oct 1;7(5):15. doi: 10.1167/tvst.7.5.15. eCollection 2018 Sep.

18.

Descemet Membrane Endothelial Keratoplasty - Complication and management of a single case for tissue preparation and graft size linked to post-op descemetorhexis disparity.

Parekh M, Ruzza A, Kaye A, Steger B, Kaye SB, Romano V.

Am J Ophthalmol Case Rep. 2018 Sep 6;12:65-67. doi: 10.1016/j.ajoc.2018.09.003. eCollection 2018 Dec.

19.

Improving precision for detecting change in the shape of the cornea in patients with keratoconus.

Brunner M, Czanner G, Vinciguerra R, Romano V, Ahmad S, Batterbury M, Britten C, Willoughby CE, Kaye SB.

Sci Rep. 2018 Aug 17;8(1):12345. doi: 10.1038/s41598-018-30173-7.

20.

Effect of storage time and temperature on the detection of Pseudomonas aeruginosa, Acanthamoeba and Herpes Simplex Virus from corneal impression membranes.

Somerville TF, Corless CE, Neal T, Kaye SB.

J Med Microbiol. 2018 Sep;67(9):1321-1325. doi: 10.1099/jmm.0.000812. Epub 2018 Jul 27.

PMID:
30051806
21.

Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials.

Sundar R, McVeigh T, Dolling D, Petruckevitch A, Diamantis N, Ang JE, Chenard-Poiriér M, Collins D, Lim J, Ameratunga M, Khan K, Kaye SB, Banerji U, Lopez J, George AJ, de Bono JS, van der Graaf WT.

Eur J Cancer. 2018 Sep;101:55-61. doi: 10.1016/j.ejca.2018.06.003. Epub 2018 Jul 17.

22.

Imaging of Corneal Neovascularization: Optical Coherence Tomography Angiography and Fluorescence Angiography.

Brunner M, Romano V, Steger B, Vinciguerra R, Lawman S, Williams B, Hicks N, Czanner G, Zheng Y, Willoughby CE, Kaye SB.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1263-1269. doi: 10.1167/iovs.17-22035.

PMID:
29625447
23.

The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.

McVeigh TP, Sundar R, Diamantis N, Kaye SB, Banerji U, Lopez JS, de Bono J, van der Graaf WTA, George AJ.

Eur J Cancer. 2018 May;95:20-29. doi: 10.1016/j.ejca.2018.02.028. Epub 2018 Mar 31.

24.

Progression of Keratoconus in Patients While Awaiting Corneal Cross-linking: A Prospective Clinical Study.

Romano V, Vinciguerra R, Arbabi EM, Hicks N, Rosetta P, Vinciguerra P, Kaye SB.

J Refract Surg. 2018 Mar 1;34(3):177-180. doi: 10.3928/1081597X-20180104-01.

PMID:
29522227
25.
26.

Possible Role of Descemet-Stroma Interface for Descemet's Membrane Detachment after Penetrating Keratoplasty.

Ho VW, Romano V, Steger B, Kaye SB.

J Ophthalmic Vis Res. 2018 Jan-Mar;13(1):72-74. doi: 10.4103/jovr.jovr_40_16.

27.

Detection and Imaging of Lymphatic and Other Vessels in Corneal Neovascular Complexes.

Romano V, Steger B, Kaye SB.

Cornea. 2018 Apr;37(4):e22-e23. doi: 10.1097/ICO.0000000000001516. No abstract available.

PMID:
29341973
28.

Deformation velocity imaging using optical coherence tomography and its applications to the cornea.

Lawman S, Madden PW, Romano V, Dong Y, Mason S, Williams BM, Kaye SB, Willoughby CE, Harding SP, Shen YC, Zheng Y.

Biomed Opt Express. 2017 Nov 13;8(12):5579-5593. doi: 10.1364/BOE.8.005579. eCollection 2017 Dec 1.

29.

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy.

Perez-Lopez R, Roda D, Jimenez B, Brown J, Mateo J, Carreira S, Lopez J, Banerji U, Molife LR, Koh DM, Kaye SB, de Bono JS, Tunariu N, Yap TA.

Oncotarget. 2017 Nov 6;8(61):104430-104443. doi: 10.18632/oncotarget.22303. eCollection 2017 Nov 28.

30.

In Vivo Early Corneal Biomechanical Changes After Corneal Cross-linking in Patients With Progressive Keratoconus.

Vinciguerra R, Romano V, Arbabi EM, Brunner M, Willoughby CE, Batterbury M, Kaye SB.

J Refract Surg. 2017 Dec 1;33(12):840-846. doi: 10.3928/1081597X-20170922-02. Erratum in: J Refract Surg. 2018 Jan 1;34(1):68.

PMID:
29227513
31.

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

Sundar R, Custodio A, Petruckevich A, Chénard-Poirier M, Ameratunga M, Collins D, Lim J, Kaye SB, Tunariu N, Banerji U, de Bono J, Lopez J.

Clin Oncol (R Coll Radiol). 2018 Mar;30(3):185-191. doi: 10.1016/j.clon.2017.11.011. Epub 2017 Dec 7.

32.

The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report.

Rauz S, Koay SY, Foot B, Kaye SB, Figueiredo F, Burdon MA, Dancey E, Chandrasekar A, Lomas R.

Eye (Lond). 2017 Nov 17. doi: 10.1038/eye.2017.209. [Epub ahead of print] No abstract available.

PMID:
29148532
33.

The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary.

Rauz S, Koay SY, Foot B, Kaye SB, Figueiredo F, Burdon MA, Dancey E, Chandrasekar A, Lomas R.

Eye (Lond). 2018 Jan;32(1):44-48. doi: 10.1038/eye.2017.208. Epub 2017 Nov 17. Review. No abstract available.

34.

Artificial Anterior Chamber Pressure and Corneal Thinning Rate in UT-DSAEK.

Parekh M, Ruzza A, Borroni D, Kaye SB, Romano V.

Cornea. 2018 Feb;37(2):e5. doi: 10.1097/ICO.0000000000001464. No abstract available.

PMID:
29135711
35.

Comparison of preservation and transportation protocols for preloaded Descemet membrane endothelial keratoplasty.

Romano V, Parekh M, Ruzza A, Willoughby CE, Ferrari S, Ponzin D, Kaye SB, Levis HJ.

Br J Ophthalmol. 2018 Apr;102(4):549-555. doi: 10.1136/bjophthalmol-2017-310906. Epub 2017 Nov 13.

36.

Identification of Feeder Vessels in Ocular Surface Neoplasia Using Indocyanine Green Angiography.

Brunner M, Steger B, Romano V, Hodson M, Zheng Y, Heimann H, Kaye SB.

Curr Eye Res. 2018 Feb;43(2):163-169. doi: 10.1080/02713683.2017.1387273. Epub 2017 Nov 7.

PMID:
29111820
37.

Detecting Change in Conjunctival Hyperemia Using a Pixel Densitometry Index.

Romano V, Steger B, Brunner M, Kaye A, Zheng Y, Willoughby CE, Kaye SB.

Ocul Immunol Inflamm. 2019;27(2):276-281. doi: 10.1080/09273948.2017.1387276. Epub 2017 Nov 2.

PMID:
29095066
38.

Gene-based antiangiogenic applications for corneal neovascularization.

Liu S, Romano V, Steger B, Kaye SB, Hamill KJ, Willoughby CE.

Surv Ophthalmol. 2018 Mar - Apr;63(2):193-213. doi: 10.1016/j.survophthal.2017.10.006. Epub 2017 Nov 15. Review.

PMID:
29080632
39.

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

Capelan M, Roda D, Geuna E, Rihawi K, Bodla S, Kaye SB, Bhosle J, Banerji U, O'Brien M, de Bono JS, Popat S, Yap TA.

Lung Cancer. 2017 Sep;111:6-11. doi: 10.1016/j.lungcan.2017.06.005. Epub 2017 Jun 15.

40.

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

Dolly SO, Migali C, Tunariu N, Della-Pepa C, Khakoo S, Hazell S, de Bono JS, Kaye SB, Banerjee S.

ESMO Open. 2017 Apr 12;2(1):e000101. doi: 10.1136/esmoopen-2016-000101. eCollection 2017.

41.

HIV-positive pregnant women attending the prevention of mother-to-child transmission of HIV/AIDS (PMTCT) services in Ethiopia: economic productivity losses across urban-rural settings.

Zegeye EA, Mbonigaba J, Kaye SB.

Psychol Health Med. 2018 Jun;23(5):525-531. doi: 10.1080/13548506.2017.1360469. Epub 2017 Jul 31.

PMID:
28760009
42.

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Ang JE, Pal A, Asad YJ, Henley AT, Valenti M, Box G, de Haven Brandon A, Revell VL, Skene DJ, Venturi M, Rueger R, Meresse V, Eccles SA, de Bono JS, Kaye SB, Workman P, Banerji U, Raynaud FI.

Mol Cancer Ther. 2017 Oct;16(10):2315-2323. doi: 10.1158/1535-7163.MCT-16-0881. Epub 2017 Jun 21.

43.

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer.

Rafii S, Gourley C, Kumar R, Geuna E, Ern Ang J, Rye T, Chen LM, Shapira-Frommer R, Friedlander M, Matulonis U, De Greve J, Oza AM, Banerjee S, Molife LR, Gore ME, Kaye SB, Yap TA.

Oncotarget. 2017 Jul 18;8(29):47154-47160. doi: 10.18632/oncotarget.17005.

44.

Preparation of ultrathin grafts for Descemet-stripping endothelial keratoplasty with a single microkeratome pass.

Romano V, Steger B, Myneni J, Batterbury M, Willoughby CE, Kaye SB.

J Cataract Refract Surg. 2017 Jan;43(1):12-15. doi: 10.1016/j.jcrs.2016.12.009.

PMID:
28317665
45.

Outcome of Descemet stripping automated endothelial keratoplasty in eyes with an Ahmed glaucoma valve.

Chiam PJ, Cheeseman R, Ho VW, Romano V, Choudhary A, Batterbury M, Kaye SB, Willoughby CE.

Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):987-993. doi: 10.1007/s00417-017-3612-2. Epub 2017 Mar 17.

PMID:
28314955
46.

Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.

George A, Kristeleit R, Rafii S, Michie CO, Bowen R, Michalarea V, van Hagen T, Wong M, Rallis G, Molife LR, Lopez J, Banerji U, Banerjee SN, Gore ME, de Bono JS, Kaye SB, Yap TA.

Eur J Cancer. 2017 May;76:52-59. doi: 10.1016/j.ejca.2017.01.020. Epub 2017 Mar 6.

PMID:
28273485
47.

Avoiding Complications Associated With Preloaded Ultrathin Descemet Stripping Automated Endothelial Keratoplasty.

Parekh M, Ruzza A, Steger B, Willoughby CE, Ferrari S, Ponzin D, Kaye SB, Romano V.

Cornea. 2017 Apr;36(4):e12-e13. doi: 10.1097/ICO.0000000000001156. No abstract available.

PMID:
28181931
48.

Development of decellularized conjunctiva as a substrate for the ex vivo expansion of conjunctival epithelium.

Kasbekar S, Kaye SB, Williams RL, Stewart RMK, Leow-Dyke S, Rooney P.

J Tissue Eng Regen Med. 2018 Feb;12(2):e973-e982. doi: 10.1002/term.2419. Epub 2017 Jun 12.

PMID:
28112872
49.

Angiographic Evaluation of Inflammation in Atopic Keratoconjunctivitis.

Steger B, Romano V, Kaye SB.

Ocul Immunol Inflamm. 2018;26(5):685-688. doi: 10.1080/09273948.2016.1247873. Epub 2016 Nov 30.

PMID:
27901637
50.

Intraoperative management of macroperforations of Descemet's membrane in deep anterior lamellar keratoplasty.

Steger B, Romano V, Palme C, Kaye SB.

Spektrum Augenheilkd. 2016;30(4):175-180. Epub 2016 Oct 5.

Supplemental Content

Support Center